Stock listing

Kiniksa Pharmaceuticals International, Plc

Selected listing: KNSAN · BMV · MXN · MX

Kiniksa Pharmaceuticals International, Plc (BMV:KNSAN), Health Technology. Latest release Sep 4, 2026: Kiniksa Pharmaceuticals to Present at Wells Fargo 21st…

KNSAN:BMVMXNMXUpdated September 25, 2026
Kiniksa Pharmaceuticals International, Plc logo
Ticker
BMV:KNSA/N
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BMV
Currency
MXN

About Kiniksa Pharmaceuticals International, Plc

Kiniksa Pharmaceuticals International, Plc (Ticker: KNSA) is a public company based in the United States, focusing on the development of innovative therapies for patients with serious diseases. Kiniksa is committed to advancing its pipeline of treatments to address unmet medical needs.

Latest news from Kiniksa Pharmaceuticals International, Plc

All Kiniksa Pharmaceuticals International, Plc news →

Events

Replays

  • Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2026 Earnings Call

    Tue, Jul 28, 2026 · 08:30 AM ET

    Watch
  • Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call

    Tue, Apr 28, 2026 · 08:30 AM ET

    Watch
  • Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call

    Tue, Feb 24, 2026 · 08:30 AM ET

    Watch

Research Kiniksa Pharmaceuticals International, Plc

Alternate listings